Strike Pharma are developing a novel next generation Antibody-Drug Conjugate (ADC) technology within the immuno-oncology precision medicine space, the ADAC technology. ADACs are short for Adaptable Drug Affinity Conjugates and are built to improve the delivery of tailor-made synthetic molecules to specific cell types for improved immune modulation.
Location: Sweden, Uppsala
Investors 2
| Date | Name | Website |
| 03.03.2022 | Flerie Inv... | flerie.com |
| - | Eir Ventur... | eirventure... |
Mentions in press and media 1
| Date | Title | Description |
| 09.02.2023 | Health tech startups are developing a personalised approach to diagnosing and treating complex health conditions | Diagnosing and treating complex health conditions has plagued health professionals forever. In response, we’re in an era of personalised or precision medicine, an approach which endeavours to tailor preventative and treatment strategies to ... |